Eleonora Cavani

Eleonora Cavani is a seasoned professional with a focus on combating chronic diseases since childhood at Alba Health, utilizing cutting-edge microbiome science and the world's largest database.

With over 10 years of experience at the nexus of science, data, and business, Eleonora has led impactful projects, including developing a machine learning model for COVID-19 advising Fortune 500 companies in collaboration with Stanford.

Her expertise spans from spearheading stability studies model at Ferring Pharmaceuticals, designing and testing digital health products at LEO Pharma, to creating various enduring products like human skin explant model and brain physical model.

Eleonora pursued her education extensively, from completing the MIT - Harvard Medical School Healthcare Innovation Bootcamp to earning a Master's Degree in Pharmaceutical Design and Engineering at DTU - Technical University of Denmark.

Her academic journey also includes studies in International Business at The Chinese University of Hong Kong, Biotechnology at Università degli Studi di Modena e Reggio Emilia, and an exchange program in Biotechnology at Universitat Autònoma de Barcelona.

Previously, Eleonora held key roles such as Founder and CEO at Alba Health, Project Leader at Boston Consulting Group (BCG), Consultant at BCG, and strategic positions at Ferring Pharmaceuticals, LEO Pharma, Rensselaer Polytechnic Institute, BluSense Diagnostics ApS, and Universitat Autonoma de Barcelona.